Dysfunctional cognition and self-efficacy as mediators of symptom change in exposure therapy for agoraphobia - Systematic review and meta-analysis.

Agoraphobia CBT Dysfunctional cognition Exposure therapy Mediation Self-efficacy

Journal

Behaviour research and therapy
ISSN: 1873-622X
Titre abrégé: Behav Res Ther
Pays: England
ID NLM: 0372477

Informations de publication

Date de publication:
09 2019
Historique:
received: 26 09 2018
revised: 02 07 2019
accepted: 26 07 2019
pubmed: 3 8 2019
medline: 21 7 2020
entrez: 3 8 2019
Statut: ppublish

Résumé

Both dysfunctional and self-efficacy-related cognitions are theorized as etiological and maintaining factors in agoraphobia. Exposure therapy is an effective treatment and central component of CBT for agoraphobia, but the role of changes in these cognitions as a mechanism of action has not been established. The present review aims to evaluate (a) whether exposure without cognitive interventions elicits changes in cognitive variables and (b) whether cognitive changes mediate outcomes in exposure-based treatments. We searched PsycInfo and PubMed for studies on agoraphobia (with or without panic disorder) and exposure as a treatment component. Fifteen articles with 29 relevant study arms (N = 921) were identified for a meta-analysis of cognitive changes after exposure. Seventeen articles (N = 1881) were included in a systematic narrative review of cognitive mediation. A random effects model revealed a large effect of cognitive improvement after pure exposure treatments, d = 1.02 (95% CI 0.81-1.23). The systematic review mostly supported changes in cognition as mediators of symptom change. Improved study designs and statistical methods in future mediation studies are needed to strengthen causal interpretation. Cognitive change is a probable mechanism of action in exposure therapy, especially change in self-efficacy. The present review suggests novel ways in which cognitive interventions can augment exposure therapy.

Identifiants

pubmed: 31374484
pii: S0005-7967(19)30129-9
doi: 10.1016/j.brat.2019.103443
pii:
doi:

Types de publication

Journal Article Meta-Analysis Research Support, Non-U.S. Gov't Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

103443

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Auteurs

Christoph Breuninger (C)

Department of Clinical Psychology and Psychotherapy, University of Freiburg, Freiburg, Germany. Electronic address: christoph.breuninger@psychologie.uni-freiburg.de.

Brunna Tuschen-Caffier (B)

Department of Clinical Psychology and Psychotherapy, University of Freiburg, Freiburg, Germany.

Jennifer Svaldi (J)

Department of Clinical Psychology and Psychotherapy, University of Tübingen, Tübingen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH